Literature DB >> 27525621

Correlation of Superior Canal Dehiscence Surface Area With Vestibular Evoked Myogenic Potentials, Audiometric Thresholds, and Dizziness Handicap.

Jacob B Hunter1, Brendan P O'Connell, Jianing Wang, Srijata Chakravorti, Katie Makowiec, Matthew L Carlson, Benoit Dawant, Devin L McCaslin, Jack H Noble, George B Wanna.   

Abstract

OBJECTIVE: To correlate objective measures of vestibular and audiometric function as well as subjective measures of dizziness handicap with the surface area of the superior canal dehiscence (SCD). STUDY
DESIGN: Retrospective chart review and radiological analysis.
SETTING: Single tertiary academic referral center. PATIENTS: Preoperative computed tomography imaging, patient survey, audiometric thresholds, and vestibular evoked myogenic potential (VEMP) testing in patients with confirmed SCD. INTERVENTION(S): Image analysis techniques were developed to measure the surface area of each SCD in computed tomography imaging. MAIN OUTCOME MEASURE(S): Preoperative ocular and cervical VEMPs, air and bone conduction thresholds, air-bone gap, dizziness handicap inventory scores, and surface area of the SCD.
RESULTS: Fifty-three patients (mean age 52.7 yr) with 84 SCD were analyzed. The median surface area of dehiscence was 1.44 mm (0.068-8.23 mm). Ocular VEMP amplitudes (r = 0.61, p <0.0001), cervical VEMP amplitudes (r = 0.62, p <0.0001), air conduction thresholds at 250 Hz (r = 0.25, p = 0.043), and air-bone gap at 500 Hz (r = 0.27, p = 0.01) positively correlated with increasing size of dehiscence. An inverse relationship between cervical VEMP thresholds (r = -0.56, p < 0.0001) and surface area of the dehiscence was observed. No association between dizziness handicap and surface area was identified.
CONCLUSION: Among patients with confirmed SCD, ocular and cervical VEMP amplitudes, cervical VEMP thresholds, and air conduction thresholds at 250 Hz are significantly correlated with the surface area of the dehiscence.

Entities:  

Mesh:

Year:  2016        PMID: 27525621      PMCID: PMC4988327          DOI: 10.1097/MAO.0000000000001126

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  24 in total

1.  Measurements of human middle- and inner-ear mechanics with dehiscence of the superior semicircular canal.

Authors:  Wade Chien; Michael E Ravicz; John J Rosowski; Saumil N Merchant
Journal:  Otol Neurotol       Date:  2007-02       Impact factor: 2.311

2.  Multislice computed tomography overestimates superior semicircular canal dehiscence syndrome.

Authors:  Massimo Re; Federico Maria Gioacchini; Ugo Salvolini; Anna Maria Totaro; Andrea Santarelli; Vito Mallardi; Giuseppe Magliulo
Journal:  Ann Otol Rhinol Laryngol       Date:  2013-10       Impact factor: 1.547

3.  Balance dysfunction and recovery after surgery for superior canal dehiscence syndrome.

Authors:  Kristen L Janky; M Geraldine Zuniga; John P Carey; Michael Schubert
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2012-08

4.  Superior semicircular canal dehiscence syndrome as assessed by oVEMP and temporal bone computed tomography imaging.

Authors:  Elsaeid M Thabet; Ahmad Abdelkhalek; Hesham Zaghloul
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-23       Impact factor: 2.503

5.  Sound- and/or pressure-induced vertigo due to bone dehiscence of the superior semicircular canal.

Authors:  L B Minor; D Solomon; J S Zinreich; D S Zee
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1998-03

6.  Superior canal dehiscence length and location influences clinical presentation and audiometric and cervical vestibular-evoked myogenic potential testing.

Authors:  Marlien E F Niesten; Leena M Hamberg; Joshua B Silverman; Kristina V Lou; Andrew A McCall; Alanna Windsor; Hugh D Curtin; Barbara S Herrmann; Wilko Grolman; Hideko H Nakajima; Daniel J Lee
Journal:  Audiol Neurootol       Date:  2014-01-09       Impact factor: 1.854

7.  The relationship between the air-bone gap and the size of superior semicircular canal dehiscence.

Authors:  Heng-Wai Yuen; Rudolf Boeddinghaus; Robert H Eikelboom; Marcus D Atlas
Journal:  Otolaryngol Head Neck Surg       Date:  2009-10-31       Impact factor: 3.497

8.  Clinical, experimental, and theoretical investigations of the effect of superior semicircular canal dehiscence on hearing mechanisms.

Authors:  John J Rosowski; Jocelyn E Songer; Hideko H Nakajima; Kelly M Brinsko; Saumil N Merchant
Journal:  Otol Neurotol       Date:  2004-05       Impact factor: 2.311

9.  Superior-semicircular-canal dehiscence: effects of location, shape, and size on sound conduction.

Authors:  Namkeun Kim; Charles R Steele; Sunil Puria
Journal:  Hear Res       Date:  2013-04-03       Impact factor: 3.208

10.  Superior semicircular canal dehiscence presenting as conductive hearing loss without vertigo.

Authors:  Anthony A Mikulec; Michael J McKenna; Mitchell J Ramsey; John J Rosowski; Barbara S Herrmann; Steven D Rauch; Hugh D Curtin; Saumil N Merchant
Journal:  Otol Neurotol       Date:  2004-03       Impact factor: 2.311

View more
  4 in total

1.  The effect of superior canal dehiscence size and location on audiometric measurements, vestibular-evoked myogenic potentials and video-head impulse testing.

Authors:  Andrea Castellucci; Gianluca Piras; Valeria Del Vecchio; Francesco Maria Crocetta; Vincenzo Maiolo; Gian Gaetano Ferri; Angelo Ghidini; Cristina Brandolini
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-06-26       Impact factor: 2.503

Review 2.  Current diagnostic procedures for diagnosing vertigo and dizziness.

Authors:  Leif Erik Walther
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2017-12-18

3.  The Supine Superior Semicircular Canal Dehiscence Test.

Authors:  Carrie W Hoppes; Karen H Lambert; Chris Zalewski; Robin Pinto; Holly Burrows; Devin McCaslin
Journal:  Am J Audiol       Date:  2021-06-21       Impact factor: 1.636

Review 4.  The Contributions of Vestibular Evoked Myogenic Potentials and Acoustic Vestibular Stimulation to Our Understanding of the Vestibular System.

Authors:  Sally M Rosengren; James G Colebatch
Journal:  Front Neurol       Date:  2018-06-29       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.